1. Home
  2. OCGN vs SKYH Comparison

OCGN vs SKYH Comparison

Compare OCGN & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • SKYH
  • Stock Information
  • Founded
  • OCGN 2013
  • SKYH 2017
  • Country
  • OCGN United States
  • SKYH United States
  • Employees
  • OCGN N/A
  • SKYH N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • SKYH Military/Government/Technical
  • Sector
  • OCGN Health Care
  • SKYH Industrials
  • Exchange
  • OCGN Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • OCGN 321.7M
  • SKYH 324.6M
  • IPO Year
  • OCGN N/A
  • SKYH N/A
  • Fundamental
  • Price
  • OCGN $1.19
  • SKYH $8.91
  • Analyst Decision
  • OCGN Strong Buy
  • SKYH Strong Buy
  • Analyst Count
  • OCGN 2
  • SKYH 3
  • Target Price
  • OCGN $7.00
  • SKYH $13.83
  • AVG Volume (30 Days)
  • OCGN 3.2M
  • SKYH 113.3K
  • Earning Date
  • OCGN 11-05-2025
  • SKYH 11-12-2025
  • Dividend Yield
  • OCGN N/A
  • SKYH N/A
  • EPS Growth
  • OCGN N/A
  • SKYH N/A
  • EPS
  • OCGN N/A
  • SKYH N/A
  • Revenue
  • OCGN $5,370,000.00
  • SKYH $24,125,000.00
  • Revenue This Year
  • OCGN N/A
  • SKYH $105.29
  • Revenue Next Year
  • OCGN N/A
  • SKYH $86.48
  • P/E Ratio
  • OCGN N/A
  • SKYH N/A
  • Revenue Growth
  • OCGN 14.26
  • SKYH 95.23
  • 52 Week Low
  • OCGN $0.52
  • SKYH $8.22
  • 52 Week High
  • OCGN $1.90
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 36.58
  • SKYH 41.98
  • Support Level
  • OCGN $1.14
  • SKYH $8.22
  • Resistance Level
  • OCGN $1.22
  • SKYH $9.08
  • Average True Range (ATR)
  • OCGN 0.08
  • SKYH 0.40
  • MACD
  • OCGN -0.01
  • SKYH -0.05
  • Stochastic Oscillator
  • OCGN 28.79
  • SKYH 43.18

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

Share on Social Networks: